Escient Pharmaceuticals

OverviewSuggest Edit

Escient Pharmaceuticals is a biotechnology company that is advancing first-in-class G Protein-Coupled Receptor (GPCR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications. The Company is focused on unleashing the therapeutic potential of specific orphan GPCRs, including the novel family of Mas-Related G-Protein Receptors (Mrgprs), and will initially pursue medicines for neuro-immuno-inflammatory and autoreactive diseases.
TypePrivate
HQSan Diego, CA, US
Websiteescientpharma.com

Latest Updates

Employees (est.) (Oct 2021)41(+3%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Escient Pharmaceuticals

Alain Baron

Alain Baron

Co-Founder, CEO
Marcus Boehm

Marcus Boehm

Co-Founder, Chief Scientific Officer
Richard Pittner

Richard Pittner

VP, Head of Biology
Show more

Escient Pharmaceuticals Office Locations

Escient Pharmaceuticals has an office in San Diego
San Diego, CA, US (HQ)
10578 Science Center Dr #250
Show all (1)

Escient Pharmaceuticals Financials and Metrics

Summary Metrics

Escient Pharmaceuticals total Funding

$117.5 m

Escient Pharmaceuticals latest funding size

$77.5 m

Time since last funding

a year ago

Escient Pharmaceuticals investors

Escient Pharmaceuticals's latest funding round in September 2020 was reported to be $77.5 m. In total, Escient Pharmaceuticals has raised $117.5 m
Show all financial metrics

Escient Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Escient Pharmaceuticals Online and Social Media Presence

Embed Graph

Escient Pharmaceuticals Blogs

Escient Pharmaceuticals Announces Positive Results from Phase 1 Study of EP547, an MrgprX4-Targeted Oral Therapy for Cholestatic and Uremic Pruritus

– EP547 was safe, well-tolerated at all doses tested and demonstrated a dose-linear PK profile supportive of oral, once-daily dosing – SAN DIEGO, CA, July 14, 2021 — Escient Pharmaceuticals, a clinical-stage, Mas-Related G Protein-Coupled Receptor (Mrgpr)-based platform company focused on discoverin…

Associate Director, Clinical Science

Based in San Diego, CA, Escient Pharmaceuticals is a clinical-stage biotech company strategically focused on unleashing the therapeutic potential of Mas-Related G-Protein Receptors (Mrgprs) for a broad range of therapeutic indications. Our diverse team at Escient shares a passion for discovering and…

Senior Manager, Clinical Operations

Based in San Diego, CA, Escient Pharmaceuticals is a clinical-stage biotech company strategically focused on unleashing the therapeutic potential of Mas-Related G-Protein Receptors (Mrgprs) for a broad range of therapeutic indications. Our diverse team at Escient shares a passion for discovering and…

Escient Pharmaceuticals Names Eric Deng, Ph.D., M.B.A. as Vice President, CMC Operations

SAN DIEGO, CA, May 27, 2021 — Escient Pharmaceuticals, Inc., a clinical-stage, industry-leading platform company developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications, today announced that E…

Escient Pharmaceuticals Appoints Christian Weyer, M.D., M.A.S., as President and Chief Medical Officer

SAN DIEGO, CA, May 17, 2021 — Escient Pharmaceuticals, Inc., a clinical-stage, industry-leading platform company developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications, today announced that C…

Escient Pharmaceuticals Names Svetlana Makhni as Chief Financial Officer

SAN DIEGO, CA, May 3, 2021 — Escient Pharmaceuticals, Inc., a clinical-stage, industry-leading platform company developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, unserved medical needs across a broad range of therapeutic indications, today announced the app…
Show more

Escient Pharmaceuticals Frequently Asked Questions

  • Who are Escient Pharmaceuticals key executives?

    Escient Pharmaceuticals's key executives are Alain Baron, Marcus Boehm and Richard Pittner.

  • How many employees does Escient Pharmaceuticals have?

    Escient Pharmaceuticals has 41 employees.

  • Who are Escient Pharmaceuticals competitors?

    Competitors of Escient Pharmaceuticals include Confo Therapeutics, Alkahest and Marinomed.

  • Where is Escient Pharmaceuticals headquarters?

    Escient Pharmaceuticals headquarters is located at 10578 Science Center Dr #250, San Diego.

  • Where are Escient Pharmaceuticals offices?

    Escient Pharmaceuticals has an office in San Diego.

  • How many offices does Escient Pharmaceuticals have?

    Escient Pharmaceuticals has 1 office.